Am I Next? Layoffs at Purdue Pharma - Oxy-Contin

The opioid crisis extends beyond the drug’s illegal users, to include an additional 350 employees at Stamford, Connecticut-based Purdue Pharma, a manufacturer of OxyContin after the drug manufacturer laid off 200 salespeople in February 2018 who were promoting the opioid to physicians.

It is somewhat ironic that Purdue was profiting from both ends of the drug chain, supplying OxyContin and Symproic, a drug used to treat opioid-induced constipation.  

Purdue is facing a number of lawsuits that alleged that the dangers of OxyContin were understated.

However, what nobody is saying is that the vast majority of the opioid crisis does not arise with those seeking pain relief through conventional medical treatment, but from street drugs manufactured in Mexico, North Korea, Venezuela, and elsewhere. Especially Fentanyl and Heroin. Many of the lawsuits are motivated and pursued by shyster trial lawyers looking for yet another big payday. It is unacceptable that reputable physicians are afraid to prescribe adequate pain medications for fear of being investigated and charged by a politically-motivated prosecutor.

Are you wondering, Am I Next?